Effect of shape of sodium salicylate particles on physical property and in vitro aerosol performance of granules prepared by pressure swing granulation method

AAPS PharmSciTech

Volumn 4, Issue 4, 2003, Pages

  Watanabe, Masayuki ^a   Ozeki, Tetsuya ^a   Shibata, Tomoko ^a   Murakoshi, Hayato ^a   Takashima, Yuuki ^a   Yuasa, Hiroshi ^a   Okada, Hiroaki ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Aerosol performance; Dry powder inhalation; Particle shape; Pressure swing granulation

Indexed keywords

SALICYLATE SODIUM;

ADHESION; AEROSOL; AQUEOUS SOLUTION; ARTICLE; CALCULATION; CRUSHING STRENGTH; DRUG GRANULATION; DRUG GRANULE; FORCE; IN VITRO STUDY; PARTICLE SIZE; POROSITY; PRESSURE; SPRAY DRYING; CHEMISTRY; PHARMACEUTICS; POWDER;

ADHESIONS; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; PARTICLE SIZE; POWDERS; PRESSURE; SODIUM SALICYLATE; TECHNOLOGY, PHARMACEUTICAL;

EID: 23144454100     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040464     Document Type: Article

References (28)

1. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm. 1994;101:1-13.
2. Geldart D. Types of gas fluidization. Powder Technol. 1973;7:285-292.
3. Newman SP, Hollingworth A, Clark AR. Effect of different modes of inhalation on drug delivery from a dry powder inhaler. Int J Pharm. 1994;102:127-132.
4. Clark, AR. Medical aerosol inhalers: past, present, and future. Aerosol Sci Technol. 1995;22:374-391.
5. Steckel H, Muler B. In vitro evaluation of dry powder inhalers: influence of carrier particle size and concentration on in vitro deposition. Int J Pharm. 1997;154:31-37.
6. Hino T, Serigano T, Yamamoto H, Takeuchi H, Niwa T, Kawashima Y. Particle design of Wogon extract dry powder inhalation aerosols with granulation method. Int J Pharm. 1998;168:59-68.
7. Kawashima Y, Serigano T, Hino T, Yamamoto H, Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int J Pharm. 1998;172:179-188.
8. Keller M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int J Pharm. 1999;186:81-90.
9. Karhu M, Kuikka J, Kauppinen T, Bergstrom K, Vidgren M. Pulmonary deposition of lactose carriers used in inhalation powders. Int J Pharm. 2000;196:95-103
10. Staniforth JN, Rees JE. Electrostatic charge interactions in ordered powder mixes. J Pharm Pharmacol. 1982;34:69-76.
11. Davies PJ, Hanlon GW, Molyneux AJ. An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified "Kirk lung." J Pharm Pharmacol. 1976; 28:908-911.
12. Vidgren M, Karkkainen A, Karjalainen P, Paronen P, Nuutinen J. Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm. 1988;42:211-216.
13. Nishii K, Ito Y, Kawashima N, Horio M. Pressure swing granulation, a novel binderless granulation by cyclic fluidization and gas flow compaction. Powder Technol. 1996;74:1-6.
14. Mikami T, Kamiya H, Horio M. Numerical simulation of cohesive powder behavior in fluidized bed. Chem Eng Sci. 1988;53:1927-1940.
15. Yuasa H, Higashi S, Ozeki T. Preparation of granules for dry powder inhaler by pressure swing granulation method and drug particle delivery. J Pharm Sci Technol Jpn. 2002;62:67-79.
16. Yuasa H, Higashi S, Ozeki T. Granulation for dry powder inhaler granules having low hardness by pressure swing granulation method and drug particle delivery in using several kinds of inhalation devices. J Japan Soc Pharm Machinery Eng. 2002;11:6-12.
17. Watanabe M, Ozeki T, Torii Y, Shibata T, Murakoshi H, Takashima Y, Yuasa H, Okada H. Preparation of two-drug composite granules for dry powder inhalation by pressure swing granulation method and evaluation of their in vitro aerosol performance to lung. J Pharm Sci Technol Jpn. 2003;63:148-157
18. The Handbook of the Japanese Pharmacopoeia. 14th ed. Tokyo, Japan: Hirokawa Publishing Co; 2001:C1383-C1386.
19. The Handbook of the Japanese Pharmacopoeia. 14th ed. Tokyo, Japan: Hirokawa Publishing Co; 2001:B569-B576.
20. Rumpf H. Zur theorie der zugfestigkeit von agglomeraten bei kraftubertragung an kontaktpunkten. Chem Ing Tech. 1970; 42:538-540.
21. Ikegami K, Kawashima Y, Takeuchi H, Yamamoto H, Mimura K, Momose D, Ouchi K. A new spherically agglomerated drug composite system with lactose for dry powder inhalation. Adv Powder Technol. 2003;14:215-229.
22. Ikegami K, Kawashima Y, Takeuchi H, Yamamoto H, Mimura K, Momose D, Ouchi K. A new agglomerated KSR-592 b-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo. J Control Release. 2003;88:23-33.
23. Hino T, Serigano T, Yamamoto H, Takeuchi H, Niwa T, Kawashima Y. Assessment of inertial separation techniques used for pressurized metered dose inhalers to evaluate respiratory deposition of aerosolized Wogon extract dry powder in vitro. STP Pharmacia Sciences. 1997;7:307-314.
24. Pitcairn GR, Lankinen T, Seppala OP, Newman SP. Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort. J Aerosol Med. 2000;13:97-104.
25. Newman SP, Pitcairn GR, Adkin DA, Vidgren MT, Silvasti M. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer. J Aerosol Med. 2001;14(2):217-225.
26. Hirst PH, Bacon RE, Pitcairn GR, Silvasti M, Newman SP. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients. Respir Med. 2001;95:720-727.
27. Harjunen P, Lehto VP, Martimo K, Suihko E, Lankinen T, Paronen P, Jarbvinen K. Lactose modification enhance its drug performance in the novel multiple dose Taifun DPI. Eur J Pharm Sci. 2002;16:313-321.
28. Kinnarinen T, Jarho P, Jarvinen K, Jarvinen T. Pulmonary deposition of a budesonide/gamma-cyclodextrin complex in vitro. J Control Release. 2003;90:197-205.